These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 39221674)
1. Microchip Based Isolation and Drug Delivery of Patient-Derived Extracellular Vesicles Against Their Homologous Tumor. Ge K; Ren Y; Hong Z; Mao Z; Yao B; Ye K; Jia C Adv Healthc Mater; 2024 Sep; ():e2401990. PubMed ID: 39221674 [TBL] [Abstract][Full Text] [Related]
2. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy. Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094 [TBL] [Abstract][Full Text] [Related]
3. Desialylated Mesenchymal Stem Cells-Derived Extracellular Vesicles Loaded with Doxorubicin for Targeted Inhibition of Hepatocellular Carcinoma. Yang C; Guan Z; Pang X; Tan Z; Yang X; Li X; Guan F Cells; 2022 Aug; 11(17):. PubMed ID: 36078050 [TBL] [Abstract][Full Text] [Related]
4. Surface Engineering of HEK293 Cell-Derived Extracellular Vesicles for Improved Pharmacokinetic Profile and Targeted Delivery of IL-12 for the Treatment of Hepatocellular Carcinoma. Zhang J; Song H; Dong Y; Li G; Li J; Cai Q; Yuan S; Wang Y; Song H Int J Nanomedicine; 2023; 18():209-223. PubMed ID: 36660339 [TBL] [Abstract][Full Text] [Related]
5. Magnetic Nanoparticle-Based Microfluidic Platform for Automated Enrichment of High-Purity Extracellular Vesicles. Guo X; Hu F; Yong Z; Zhao S; Wan Y; Wang B; Peng N Anal Chem; 2024 May; 96(18):7212-7219. PubMed ID: 38660946 [TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles derived from dendritic cells loaded with VEGF-A siRNA and doxorubicin reduce glioma angiogenesis in vitro. Shamshiripour P; Rahnama M; Nikoobakht M; Rad VF; Moradi AR; Ahmadvand D J Control Release; 2024 May; 369():128-145. PubMed ID: 38522817 [TBL] [Abstract][Full Text] [Related]
7. Heterologous and cross-species tropism of cancer-derived extracellular vesicles. Garofalo M; Villa A; Crescenti D; Marzagalli M; Kuryk L; Limonta P; Mazzaferro V; Ciana P Theranostics; 2019; 9(19):5681-5693. PubMed ID: 31534511 [TBL] [Abstract][Full Text] [Related]
8. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization. Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876 [TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review. Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061 [TBL] [Abstract][Full Text] [Related]
10. Application of engineered extracellular vesicles for targeted tumor therapy. Zhang F; Guo J; Zhang Z; Duan M; Wang G; Qian Y; Zhao H; Yang Z; Jiang X J Biomed Sci; 2022 Feb; 29(1):14. PubMed ID: 35189894 [TBL] [Abstract][Full Text] [Related]
11. Extracellular-vesicles delivered tumor-specific sequential nanocatalysts can be used for MRI-informed nanocatalytic Therapy of hepatocellular carcinoma. Wu H; Xing H; Wu MC; Shen F; Chen Y; Yang T Theranostics; 2021; 11(1):64-78. PubMed ID: 33391461 [No Abstract] [Full Text] [Related]
12. Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles. Li H; Xu W; Li F; Zeng R; Zhang X; Wang X; Zhao S; Weng J; Li Z; Sun L Drug Deliv; 2022 Dec; 29(1):192-202. PubMed ID: 34984953 [TBL] [Abstract][Full Text] [Related]
13. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System. Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615 [TBL] [Abstract][Full Text] [Related]
14. Single-particle assessment of six different drug-loading strategies for incorporating doxorubicin into small extracellular vesicles. Chen C; Li Y; Wang Q; Cai N; Wu L; Yan X Anal Bioanal Chem; 2023 Mar; 415(7):1287-1298. PubMed ID: 35945289 [TBL] [Abstract][Full Text] [Related]
15. Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells. Takenaka T; Nakai S; Katayama M; Hirano M; Ueno N; Noguchi K; Takatani-Nakase T; Fujii I; Kobayashi SS; Nakase I Int J Pharm; 2019 Dec; 572():118762. PubMed ID: 31610280 [TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles for drug delivery. Vader P; Mol EA; Pasterkamp G; Schiffelers RM Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656 [TBL] [Abstract][Full Text] [Related]
17. Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug delivery. Meng W; Wang L; Du X; Xie M; Yang F; Li F; Wu ZE; Gan J; Wei H; Cao C; Lu S; Cao B; Li L; Li L; Zhu G J Control Release; 2023 Nov; 363():235-252. PubMed ID: 37739016 [TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells. Draguet F; Dubois N; Bouland C; Pieters K; Bron D; Meuleman N; Stamatopoulos B; Lagneaux L Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296864 [TBL] [Abstract][Full Text] [Related]
19. Stem Cell-derived Extracellular Vesicles: A Promising Nano Delivery Platform to the Brain? Guo Y; Hu D; Lian L; Zhao L; Li M; Bao H; Xu S Stem Cell Rev Rep; 2023 Feb; 19(2):285-308. PubMed ID: 36173500 [TBL] [Abstract][Full Text] [Related]